Anti-Inflammatory Polyketides from an Alga-Derived Fungus Aspergillus ochraceopetaliformis SCSIO 41020

Mar Drugs. 2022 Apr 27;20(5):295. doi: 10.3390/md20050295.

Abstract

A new linear polyketide, named aspormisin A (1), together with five known polyketides (2-6), were isolated from the alga-derived fungus Aspergillus ochraceopetaliformis SCSIO 41020. Their structures were elucidated through a detailed comprehensive spectroscopic analysis, as well as a comparison with the literature. An anti-inflammatory evaluation showed that compounds 2, 5, and 6 possessed inhibitory activity against the excessive production of nitric oxide (NO) and pro-inflammatory cytokines in LPS-treated RAW 264.7 macrophages in a dose-dependent manner without cytotoxicity. Further studies revealed that compound 2 was active in blocking the release of pro-inflammatory cytokines (IL-6, MCP-1, and TNF-α) induced by LPS both in vivo and in vitro. Our findings provide a basis for the further development of linear polyketides as promising anti-inflammatory agents.

Keywords: Aspergillus ochraceopetaliformis; alga-derived fungus; anti-inflammatory activity; polyketide.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Aspergillus / chemistry
  • Cytokines
  • Lipopolysaccharides / pharmacology
  • Polyketides* / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Lipopolysaccharides
  • Polyketides

Supplementary concepts

  • Aspergillus ochraceopetaliformis